Erika Schultz | executive |
John Jacobs | executive |
John Trizzino | executive |
Filip Dubovsky | executive |
James Kelly | executive |
Jiale Song | analyst |
Eric Joseph | analyst |
Brendan Smith | analyst |
Mayank Mamtani | analyst |
Alec Stranahan | analyst |
Good morning, and welcome to Novavax' Fourth Quarter 2023 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Erika Schultz, Senior Director, Investor Relations. Please go ahead.
Good morning, and thank you all for joining us today to discuss our fourth quarter and full year 2023 operational highlights and financial results.